Lung Disease
Qureight’s Synthetic Study Arms Validate Clinical Efficacy in Pioneering Rare Lung Disease Treatment
Qureight
PR-06-25-NI-06Jun 17, 2025
Clinical Trials
Poorly Reported Placebos May Lead to Mistaken Estimates of Benefits
University of Oxford
PR-M10-19-NI-004Oct 03, 2019